. 2013 Jun;17(6):470–474. doi: 10.1089/gtmb.2012.0518

Table 1.

IC50 Values (μg/mL) of Anti-Cancer Drugs for Esophageal Cancer Cells

	ADR	5-Flu	CDDP
ECA109	5.31±0.11	4.09±0.05	4.11±0.18
Control	5.65±0.09	4.22±0.13	4.04±0.07
miR-214 antagomir	2.22±0.04^a	1.55±0.09^a	1.37±0.08^a
miR-483 antagomir	1.89±0.17^b	1.68±0.11^b	1.62±0.12^a

Survival rates of esophageal cancer cells to anticancer drugs were evaluated by MTT assay. The dose–effect curves of anticancer drugs were drawn on semi-logarithm coordinate paper and IC50 values were determined. Data were represented as mean±SD of three independent experiments. ^ap<0.05 versus Eca109 and control cells.

ADR, adriamycin; 5-flu, 5-fludrouracil; CDDP, cisplatin.